Achieving Robust QC Standards in 3D Vasculature Models to Enable Confident Preclinical Implementation
9:30 am - Thursday 30th April 2026
- Establishing reproducible quality control protocols for 96-well 3D vasculature models to ensure device readiness across multiple plates
- Validating barrier integrity measurements in outsourced 3D vasculature systems to accelerate compound screening with minimal internal development
- Implementing scalable pre-clinical screening workflows using ready-to-use 3D models to enable rapid adoption for future therapeutic programs
